170 related articles for article (PubMed ID: 28815577)
1. Emerging roles of rhomboid-like pseudoproteases in inflammatory and innate immune responses.
Luo WW; Shu HB
FEBS Lett; 2017 Oct; 591(20):3182-3189. PubMed ID: 28815577
[TBL] [Abstract][Full Text] [Related]
2. iRhom2: An Emerging Adaptor Regulating Immunity and Disease.
Al-Salihi MA; Lang PA
Int J Mol Sci; 2020 Sep; 21(18):. PubMed ID: 32911849
[TBL] [Abstract][Full Text] [Related]
3. ADAM17 stabilizes its interacting partner inactive Rhomboid 2 (iRhom2) but not inactive Rhomboid 1 (iRhom1).
Weskamp G; Tüshaus J; Li D; Feederle R; Maretzky T; Swendemann S; Falck-Pedersen E; McIlwain DR; Mak TW; Salmon JE; Lichtenthaler SF; Blobel CP
J Biol Chem; 2020 Mar; 295(13):4350-4358. PubMed ID: 32060096
[TBL] [Abstract][Full Text] [Related]
4. The Rhomboid Superfamily: Structural Mechanisms and Chemical Biology Opportunities.
Tichá A; Collis B; Strisovsky K
Trends Biochem Sci; 2018 Sep; 43(9):726-739. PubMed ID: 30055896
[TBL] [Abstract][Full Text] [Related]
5. Emerging role of rhomboid family proteins in mammalian biology and disease.
Bergbold N; Lemberg MK
Biochim Biophys Acta; 2013 Dec; 1828(12):2840-8. PubMed ID: 23562403
[TBL] [Abstract][Full Text] [Related]
6. The molecular, cellular and pathophysiological roles of iRhom pseudoproteases.
Dulloo I; Muliyil S; Freeman M
Open Biol; 2019 Mar; 9(3):190003. PubMed ID: 30890028
[TBL] [Abstract][Full Text] [Related]
7. Status update on iRhom and ADAM17: It's still complicated.
Düsterhöft S; Babendreyer A; Giese AA; Flasshove C; Ludwig A
Biochim Biophys Acta Mol Cell Res; 2019 Oct; 1866(10):1567-1583. PubMed ID: 31330158
[TBL] [Abstract][Full Text] [Related]
8. The complex life of rhomboid pseudoproteases.
Adrain C; Cavadas M
FEBS J; 2020 Oct; 287(19):4261-4283. PubMed ID: 32894651
[TBL] [Abstract][Full Text] [Related]
9. Mechanistic insight on the role of iRhom2-TNF-α-BAFF signaling pathway in various autoimmune disorders.
Dwivedi SD; Shukla R; Yadav K; Rathor LS; Singh D; Singh MR
Adv Biol Regul; 2024 May; 92():101011. PubMed ID: 38151421
[TBL] [Abstract][Full Text] [Related]
10. iRHOM2-dependent regulation of ADAM17 in cutaneous disease and epidermal barrier function.
Brooke MA; Etheridge SL; Kaplan N; Simpson C; O'Toole EA; Ishida-Yamamoto A; Marches O; Getsios S; Kelsell DP
Hum Mol Genet; 2014 Aug; 23(15):4064-76. PubMed ID: 24643277
[TBL] [Abstract][Full Text] [Related]
11. Novel functions of inactive rhomboid proteins in immunity and disease.
Geesala R; Issuree PD; Maretzky T
J Leukoc Biol; 2019 Oct; 106(4):823-835. PubMed ID: 31369701
[TBL] [Abstract][Full Text] [Related]
12. iRhom2 regulates ERBB signalling to promote KRAS-driven tumour growth of lung cancer cells.
Sieber B; Lu F; Stribbling SM; Grieve AG; Ryan AJ; Freeman M
J Cell Sci; 2022 Sep; 135(17):. PubMed ID: 35971826
[TBL] [Abstract][Full Text] [Related]
13. iRhom2 is essential for innate immunity to DNA viruses by mediating trafficking and stability of the adaptor STING.
Luo WW; Li S; Li C; Lian H; Yang Q; Zhong B; Shu HB
Nat Immunol; 2016 Sep; 17(9):1057-66. PubMed ID: 27428826
[TBL] [Abstract][Full Text] [Related]
14. FRMD8 promotes inflammatory and growth factor signalling by stabilising the iRhom/ADAM17 sheddase complex.
Künzel U; Grieve AG; Meng Y; Sieber B; Cowley SA; Freeman M
Elife; 2018 Jun; 7():. PubMed ID: 29897336
[TBL] [Abstract][Full Text] [Related]
15. iTAP, a novel iRhom interactor, controls TNF secretion by policing the stability of iRhom/TACE.
Oikonomidi I; Burbridge E; Cavadas M; Sullivan G; Collis B; Naegele H; Clancy D; Brezinova J; Hu T; Bileck A; Gerner C; Bolado A; von Kriegsheim A; Martin SJ; Steinberg F; Strisovsky K; Adrain C
Elife; 2018 Jun; 7():. PubMed ID: 29897333
[TBL] [Abstract][Full Text] [Related]
16. The iRhom homology domain is indispensable for ADAM17-mediated TNFα and EGF receptor ligand release.
Düsterhöft S; Kahveci-Türköz S; Wozniak J; Seifert A; Kasparek P; Ohm H; Liu S; Kopkanova J; Lokau J; Garbers C; Preisinger C; Sedlacek R; Freeman M; Ludwig A
Cell Mol Life Sci; 2021 Jun; 78(11):5015-5040. PubMed ID: 33950315
[TBL] [Abstract][Full Text] [Related]
17. Inactive rhomboid proteins: New mechanisms with implications in health and disease.
Lemberg MK; Adrain C
Semin Cell Dev Biol; 2016 Dec; 60():29-37. PubMed ID: 27378062
[TBL] [Abstract][Full Text] [Related]
18. iRHOM2 is a critical pathogenic mediator of inflammatory arthritis.
Issuree PD; Maretzky T; McIlwain DR; Monette S; Qing X; Lang PA; Swendeman SL; Park-Min KH; Binder N; Kalliolias GD; Yarilina A; Horiuchi K; Ivashkiv LB; Mak TW; Salmon JE; Blobel CP
J Clin Invest; 2013 Feb; 123(2):928-32. PubMed ID: 23348744
[TBL] [Abstract][Full Text] [Related]
19. Cleavage of the pseudoprotease iRhom2 by the signal peptidase complex reveals an ER-to-nucleus signaling pathway.
Dulloo I; Tellier M; Levet C; Chikh A; Zhang B; Blaydon DC; Webb CM; Kelsell DP; Freeman M
Mol Cell; 2024 Jan; 84(2):277-292.e9. PubMed ID: 38183983
[TBL] [Abstract][Full Text] [Related]
20. iRhom2 regulation of TACE controls TNF-mediated protection against Listeria and responses to LPS.
McIlwain DR; Lang PA; Maretzky T; Hamada K; Ohishi K; Maney SK; Berger T; Murthy A; Duncan G; Xu HC; Lang KS; Häussinger D; Wakeham A; Itie-Youten A; Khokha R; Ohashi PS; Blobel CP; Mak TW
Science; 2012 Jan; 335(6065):229-32. PubMed ID: 22246778
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
